
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.960 | 1.880 | 0.920 |
Shares | 99.040 | 99.040 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 24.173 | 30.988 |
Price to Book | 3.008 | 3.619 |
Price to Sales | 3.318 | 4.995 |
Price to Cash Flow | 15.378 | 19.840 |
Dividend Yield | 0.741 | 0.743 |
5 Years Earnings Growth | 16.104 | 17.877 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 91.330 | 95.956 |
Basic Materials | 5.830 | 5.710 |
Financial Services | 2.850 | 2.150 |
Number of long holdings: 45
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 13.21 | 1,748.40 | +0.20% | |
Cipla | INE059A01026 | 9.55 | 1,523.00 | +0.79% | |
Dr Reddy’s Laboratories | INE089A01031 | 8.94 | 1,175.10 | -0.20% | |
Divi's Labs | INE361B01024 | 6.78 | 5,909.50 | +0.31% | |
Aurobindo Pharma | INE406A01037 | 5.15 | 1,189.50 | -0.97% | |
Lupin | INE326A01037 | 4.73 | 2,040.80 | +1.57% | |
Alkem Laboratories Ltd | INE540L01014 | 4.49 | 5,017.30 | +0.34% | |
Gland | INE068V01023 | 3.52 | 1,450.30 | -0.96% | |
Zydus Lifesciences | INE010B01027 | 3.27 | 851.50 | +0.73% | |
Mankind Pharma | INE634S01028 | 2.85 | 2,573.65 | -0.38% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ICICI Focused Bluechip Equity RetGr | 649.63B | -0.81 | 16.21 | 13.32 | ||
ICICI Focused Bluechip Eq RetailDiv | 649.63B | -1.52 | 15.38 | 12.52 | ||
ICICI Prud Focused Bluechip Div | 649.63B | -0.90 | 16.64 | 13.81 | ||
ICICI Prud Focused Bluechip Gr | 649.63B | -0.68 | 16.89 | 14.17 | ||
ICICI Balanced Adv Dir Gr | 605.91B | 0.42 | 12.56 | 11.56 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review